Precision Medicine and The Future of Genomics Summit 2024

Precision Medicine and The Future of Genomics Summit 2024

Scailyte at the Global Stage of Precision Medicine – PMFG 2024! We are proud to share that our CEO, Peter Nestorov, will present at the Precision Medicine and the Future of Genomics Summit in Doha, Qatar. The summit will bring together global experts to shape the future of healthcare in the Middle East and beyond.

Continue reading

Exploring Type 2 T Cell Immunity in Cancer—A Single-Cell Revolution

Exploring Type 2 T Cell Immunity in Cancer—A Single-Cell Revolution

In this issue of ScaiDigest, we highlight two groundbreaking studies that expand the boundaries of immunotherapy research, focusing on the underestimated role of type 2 T cell immunity in cancer. Leveraging single-cell multi-omics, these studies illuminate how type 2 immunity, often overlooked in conventional paradigms, contributes to durable cancer remission and immune modulation. Together, they represent a paradigm shift in our understanding of T cell biology, underscoring the power of single-cell data to drive unbiased and transformative discoveries.

Continue reading

Global Entrepreneurship Week Basel

Global Entrepreneurship Week Basel

Precision Medicine and The Future of Genomics Summit 2024

Precision Medicine and The Future of Genomics Summit 2024

Global Entrepreneurship Week Basel

Global Entrepreneurship Week Basel

Join Us at Global Entrepreneurship Week Basel! 

Scailyte is thrilled to be part of the Global Entrepreneurship Week (GEW) in Basel, happening from November 18 to 24, 2024. This exciting week is dedicated to celebrating and fostering the entrepreneurial spirit in our vibrant city.

What is GEW Basel?

GEW Basel is a dynamic series of events designed to inspire, connect, and support entrepreneurs. From hands-on workshops to insightful panel discussions and the elegant Basel Entrepreneurship Night, there’s something for everyone passionate about innovation and business.

Why is it Interesting?

– Networking Opportunities: Meet and connect with like-minded entrepreneurs, investors, and industry experts.

– Inspiring Sessions: Gain insights from successful entrepreneurs and thought leaders.

– Hands-On Workshops: Enhance your skills and knowledge through practical sessions.

Who Should Attend?

Whether you’re a seasoned entrepreneur, a startup enthusiast, or someone with a budding business idea, GEW Basel offers invaluable opportunities to learn, network, and grow.

Special Highlight: We are proud to announce that our co-founder & CEO Peter Nestorov will be participating in a panel discussion during the week – find more details and the registration link below. Don’t miss this chance to hear from one of the leading voices in the Basel startup community!

Let’s come together to celebrate entrepreneurship and drive innovation forward! 

Аre you a founder looking for real connections, mentorship, and opportunities to grow? Founders Connect is here to support you every step of the way! 

 

Speakers:

🎤 Maria Hahn – Scaling beyond Switzerland and Innovation in Health

🎤 Peter Nestorov – Precision Medicine 

🎤 Jennifer Cain Birkmose – Patient Access

🎤 Roberto Iannone – Zoundream

🎤 Thomas Nirnberger – BioFi AG

 

📅 Date: 21 November 6 pm to 8.30 pm

🗣️ Panel, Q&A, and Networking—connect with global experts and equip your startup for success!

👉 Don’t miss out—Register here 

Register https://lnkd.in/dcDDxE_M 

About Scailyte

Scailyte is an ETH Zürich spin-off with a best-in-class artificial intelligence platform for the discovery of complex disease patterns from single-cell data. Our solution provides unprecedented insight into the disease and patients’ biology and enables the discovery of new clinically-relevant biomarker signatures by uncovering human’s hidden “single-cell” secrets. 

Scailyte’s proprietary best-in-class data analysis platform ScaiVision™ associates multimodal single-cell datasets (RNA-/TCR-/BCR-seq, proteomics, etc.) with clinical endpoints, such as disease diagnosis, progression, severity, treatment response, and toxicity response to identify ultra-sensitive biomarker signatures and cell functionality states. The performance and clinically-relevant applications of Scailyte’s platform ScaiVision have been demonstrated in well established CAR-T cell therapies and various clinical projects in Oncology and Immunology.

For more information, visit www.scailyte.com and connect on social media @LinkedIn and @Twitter.

ScailyteTM and ScaiVisionTM are registered trademarks proprietary to Scailyte AG.

Recent News

Precision Medicine and The Future of Genomics Summit 2024

Scailyte at the Global Stage of Precision Medicine – PMFG 2024! We are proud to share that our CEO...

Read more

Recent News

Exploring Type 2 T Cell Immunity in Cancer—A Single-Cell Revolution

In this issue of ScaiDigest, we highlight two groundbreaking studies that expand the boundaries of i...

Read more

Recent News

Pitch Nic 2024 at Novartis Campus

We’re thrilled to announce that our CEO, Peter Nestorov will join the innovative minds at Pitch Ni...

Read more

Recent News

Genomics for Health 2024

Don't miss Scailyte's CEO, Peter Nestorov, at the Genomics for Health 2024 event, bridging cutting-e...

Read more

Recent News

The Year of the AI Nobel

2024 is being hailed as the "Year of the AI Nobel," marking a milestone as artificial intelligence (...

Read more

Recent News

Life Science Industry Meets Data Science Symposium

Scailyte is thrilled to be part of the LIFE SCIENCE INDUSTRY MEETS DATA SCIENCE symposium organised ...

Read more

Recent News

World CB & CDx Summit 2024

Scailyte is thrilled to attend Hanson Wade's 14th World CB & CDx Summit - the flagship CDx event of ...

Read more

Recent News

01 /04

Precision Medicine and The Future of Genomics Summit 2024

Scailyte at the Global Stage of Precision Medicine – PMFG 2024! We are proud to share that our CEO...

Read more

Exploring Type 2 T Cell Immunity in Cancer—A Single-Cell Revolution

In this issue of ScaiDigest, we highlight two groundbreaking studies that expand the boundaries of i...

Read more

Recent News

02 /04

Pitch Nic 2024 at Novartis Campus

We’re thrilled to announce that our CEO, Peter Nestorov will join the innovative minds at Pitch Ni...

Read more

Recent News

03 /04

Genomics for Health 2024

Don't miss Scailyte's CEO, Peter Nestorov, at the Genomics for Health 2024 event, bridging cutting-e...

Read more

The Year of the AI Nobel

2024 is being hailed as the "Year of the AI Nobel," marking a milestone as artificial intelligence (...

Read more

Recent News

04 /04

Life Science Industry Meets Data Science Symposium

Scailyte is thrilled to be part of the LIFE SCIENCE INDUSTRY MEETS DATA SCIENCE symposium organised ...

Read more

World CB & CDx Summit 2024

Scailyte is thrilled to attend Hanson Wade's 14th World CB & CDx Summit - the flagship CDx event of ...

Read more

Recent News

Pitch Nic 2024 at Novartis Campus

Pitch Nic 2024 at Novartis Campus

We’re thrilled to announce that our CEO, Peter Nestorov will join the innovative minds at Pitch Nic on November 21 at the Novartis Campus, hosted by Switzerland Innovation Park Basel Area and DayOne. This invitation-only event brings together pioneering healthtech startups to showcase cutting-edge innovations shaping the future of healthcare.

Continue reading